Composition analysis and mechanism of Guizhi Fuling capsule in anti-cisplatin-resistant ovarian cancer
Objective: Cisplatin is the main chemotherapy drug for advanced ovarian cancer, but drug resistance often occurs. The aim of this study is to explore the molecular mechanism by which Guizhi Fuling capsule inhibits cisplatin resistance in ovarian cancer. Methods: First, differences in cisplatin resis...
Saved in:
Main Authors: | Lei Dou, Yan Yan, Enting Lu, Fangmei Li, Dongli Tian, Lei Deng, Xue Zhang, Rongjin Zhang, Yin Li, Yi Zhang, Ye Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-02-01
|
Series: | Translational Oncology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S193652332400370X |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mechanistic insights into epithelial-mesenchymal transition mediated cisplatin resistance in ovarian cancer
by: Taha Umair Wani, et al.
Published: (2025-01-01) -
Mebendazole Exerts Anticancer Activity in Ovarian Cancer Cell Lines via Novel Girdin-Mediated AKT/IKKα/β/NF-κB Signaling Axis
by: Rahul Gupta, et al.
Published: (2025-01-01) -
Cisplatin resistance alters ovarian cancer spheroid formation and impacts peritoneal invasion
by: Lydia C. Powell, et al.
Published: (2025-02-01) -
Pyrogallol acts as a novel anticancer factor to enhance the sensitivity to cisplatin in ovarian cancer cells through inducing miR-15a upregulation
by: Azin Shirani, et al.
Published: (2025-01-01) -
Inhibition of id-1 reduces osteosarcoma growth and metastasis through mediation of snail
by: Rongbing Shu, et al.
Published: (2025-01-01)